• Maplight Therapeutics held its annual stockholder meeting on June 23, 2026.
• Stockholders backed the selection of RSM US LLP as independent registered public accounting firm for the fiscal year ending Dec. 31, 2026.
• Stockholders elected three directors to serve until the 2029 annual meeting.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Maplight Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-280243), on June 24, 2026, and is solely responsible for the information contained therein.